ArticleHealth science reports2026
Association Between Opium Consumption and Lipid Profile: A Systematic Review and Meta-Analysis of Observational Studies.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Opium, traditionally used for its analgesic and sedative properties, has been widely consumed. Given the conflicting evidence regarding its association with lipid profiles, the present study was conducted to investigate the association between opium consumption and lipid profile parameters. Methods: A comprehensive search was conducted in PubMed, Scopus, and Web of Science up to May 2025. Search results were screened in two stages by two independent reviewers. Data were extracted and the quality of the included studies was assessed using the JBI checklist. Statistical analysis was performed using STATA-17. Results: A total of 36 studies with 5660 opium users and 11,885 controls were included. The meta-analysis revealed a significant reduction in total cholesterol (WMD = -4.72, 95% CI: -8.72 to -0.71) and HDL-C (WMD = -1.95, 95% CI: -3.69 to -0.22), while no significant associations were observed for triglycerides, LDL-C, Apo-A1, and Apo-B100. Notably, gender-based subgroup analysis showed a significant association with lower TG levels in men and lower TC and LDL-C levels in women. Meta-regression analyses showed no statistically significant association between duration of opiate use and lipid parameters. Also, overall study quality was high with no evidence of publication bias. Conclusion: This comprehensive meta-analysis demonstrates that opium consumption is not associated with a clinically favorable lipid profile. While meta-regression revealed nonsignificant positive trends between the duration of opium use and lipid parameters, the overall dyslipidemic pattern indicates an unfavorable cardiovascular risk profile. Future longitudinal and multinational studies with standardized exposure assessment are essential to clarify the dose-response relationships and long-term cardiometabolic consequences of opium use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.